Table 3.
Patterns of tumor recurrence
| Patients (n = 70) | |
|---|---|
| Number of patients with HCC recurrence, n (%) | 21 (30) | 
| Site of recurrence, n (%) | |
| Intrahepatic recurrence | 16 (76.2) | 
| Extrahepatic recurrence | 3 (14.3) | 
| Both intra- and extrahepatic recurrence | 2 (9.5) | 
| Time until recurrence, n | |
| <1 year | 19 | 
| ≥1 year | 2 | 
| Major treatment for tumor recurrence, n | |
| Repeat hepatectomy | 3 | 
| Radiofrequency ablation | 4 | 
| Radiotherapy | 7 | 
| Second-line systemic therapy | 2 | 
| Systemic therapy + TACE | 2 | 
| None | 3 | 
HCC, hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization.